Economic burden of asthma: a systematic review

Katayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, Larry Lynd, Kadria Alasaly, John Swiston, J Mark FitzGerald, Katayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, Larry Lynd, Kadria Alasaly, John Swiston, J Mark FitzGerald

Abstract

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.

Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.

Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.

Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Figures

Figure 1
Figure 1
Trend in prevalence of asthma.
Figure 2
Figure 2
Results of systematic literature search.

References

    1. Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE, Jr, Michel FB. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med. 1994;149:371–5.
    1. Riccioni G, D'Orazio N, Di Ilio C, Menna V, Guagnano MT, la Vecchia R. Quality of Life and clinical symptoms in asthmatic subjects. J Asthma. 2004;41:85–9.
    1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. 2006.
    1. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Program The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–78.
    1. Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol. 2001;107:S445–S448.
    1. Morgan M, Khan DA. Asthma: epidemiology, burden and quality of life. Adv Psychosom Med. 2003;24:1–15.
    1. Sennhauser FH, Braun-Fahrlander C, Wildhaber JH. The burden of asthma in children: a European perspective. Paediatr Respir Rev. 2005;6:2–7.
    1. Woolcock AJ, Bastiampillai SA, Marks GB, Keena VA. The burden of asthma in Australia. Med J Aust. 2001;175:141–5.
    1. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275–83.
    1. Birnbaum HG, Berger WE, Greenberg PE, Holland M, Auerbach R, Atkins KM, Wanke LA. Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol. 2002;109:264–70.
    1. Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111:1212–8.
    1. Kocevar VS, Bisgaard H, Jonsson L, Valovirta E, Kristensen F, Yin DD, Thomas J., III Variations in pediatric asthma hospitalization rates and costs between and within Nordic countries. Chest. 2004;125:1680–4.
    1. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J. 1998;12:1322–6.
    1. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156:787–93.
    1. Ungar WJ, Coyte PC, Chapman KR, MacKeigan L. The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board. Can Respir J. 1998;5:463–71.
    1. Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141:189–98.
    1. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, Zhang Q, Yin DD. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23:723–9.
    1. Awadh Behbehani N, Grunfeld A, FitzGerald JM. Health care costs associated with acute asthma: a prospective economic analysis. Can Respir J. 1999;6:521–5.
    1. Celik GE, Bavbek S, Pasaoglu G, Mungan D, Abadoglu O, Harmanci E, Misirligil Z. Direct medical cost of asthma in Ankara, Turkey. Respiration. 2004;71:587–93.
    1. Chew FT, Goh DY, Lee BW. The economic cost of asthma in Singapore. Aust N Z J Med. 1999;29:228–33.
    1. Colice G, Wu EQ, Birnbaum H, Daher M, Marynchenko MB, Varghese S. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med. 2006;48:794–802.
    1. Gendo K, Sullivan SD, Lozano P, Finkelstein JA, Fuhlbrigge A, Weiss KB. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol. 2003;91:251–7.
    1. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19:61–7.
    1. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma. 2001;38:363–73.
    1. Gupta RS, Bewtra M, Prosser LA, Finkelstein JA. Predictors of hospital charges for children admitted with asthma. Ambul Pediatr. 2006;6:15–20.
    1. Herjavecz I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, Ben-Joseph R. Cost, morbidity, and control of asthma in Hungary: The Hunair Study. J Asthma. 2003;40:673–81.
    1. Jansson SA, Ronmark E, Forsberg B, Lofgren C, Lindberg A, Lundback B. The economic consequences of asthma among adults in Sweden. Respir Med. 2007;101:2263–70.
    1. Kenny P, Lancsar E, Hall J, King M, Chaplin M. The individual and health sector costs of asthma: the first year of a longitudinal study in New South Wales. Aust N Z J Public Health. 2005;29:429–35.
    1. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. CMAJ. 1996;154:821–31.
    1. Laforest L, Ernst P, Pietri G, Yin D, Pacheco Y, Bellon G, Kocevar VS, Ganse EV. Asthma-Related Costs Relative to Severity and Control in General Practice. Pediatr Asthma Allergy Immunol. 2005;18:36–45.
    1. Lai CKW, Kim YY, Kuo SH, Spencer M, Williams AE, on behalf of the Asthma Insights and Reality in Asia Pacific Steering Committee Cost of asthma in the Asia-Pacific region. Eur Respir Rev. 2006;15:10–6.
    1. Lin HC, Kao S, Wen HC, Wu CS, Chung CL. Length of stay and costs for asthma patients by hospital characteristics–a five-year population-based analysis. J Asthma. 2005;42:537–42.
    1. Lozano P, Fishman P, Von Korff M, Hecht J. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics. 1997;99:757–64.
    1. Sapra S, Nielsen K, Martin BC. The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma. 2005;42:469–77.
    1. Schwenkglenks M, Lowy A, Anderhub H, Szucs TD. Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value Health. 2003;6:75–83.
    1. Stanford R, McLaughlin T, Okamoto LJ. The cost of asthma in the emergency department and hospital. Am J Respir Crit Care Med. 1999;160:211–5.
    1. Stempel DA, Hedblom EC, Durcanin-Robbins JF, Sturm LL. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures. Arch Fam Med. 1996;5:36–40.
    1. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J. 2003;21:1000–6.
    1. Stroupe KT, Gaskins D, Murray MD. Health-care costs of inner-city patients with asthma. J Asthma. 1999;36:645–55.
    1. Sun HL, Kao YH, Lu TH, Chou MC, Lue KH. Health-care utilization and costs in Taiwanese pediatric patients with asthma. Pediatr Int. 2007;49:48–52.
    1. Toelle BG, Peat JK, Mellis CM, Woolcock AJ. The cost of childhood asthma to Australian families. Pediatr Pulmonol. 1995;19:330–5.
    1. Ungar WJ, Coyte PC, Pharmacy Medication Monitoring Program Advisory B Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol. 2001;32:101–8.
    1. Wang LY, Zhong Y, Wheeler L. Direct and indirect costs of asthma in school-age children. Prev Chronic Dis. 2005;2:A11.
    1. Meurer JR, Kuhn EM, George V, Yauck JS, Layde PM. Charges for childhood asthma by hospital characteristics. Pediatrics. 1998;102:E70.
    1. Segal R, Ried LD, Mackowiak J. Cost of asthma illnesses: emergency department visits without admission. Pharm Pract Manag Q. 1995;15:72–82.
    1. Visitsunthorn N, Durongpisitkul W, Uoonpan S, Jirapongsananuruk O, Vichyanond P. Medical charge of asthma care in admitted Thai children. J Med Assoc Thai. 2005;88:S16–S20.
    1. Mellis CM, Peat JK, Bauman AE, Woolcock AJ. The cost of asthma in New South Wales. Med J Aust. 1991;155:522–8.
    1. Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J. 1999;13:281–6.
    1. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326:862–6.
    1. Sorensen L, Weng S, Weng SL, Wulf-Andersen L, Ostergaard D, Bech PG. The cost of asthma in Denmark. Br J Med Econ. 1997;11:103–11.
    1. Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW. Asthma: prevalence and cost of illness. Eur Respir J. 2005;25:47–53.
    1. Borderias Clau L, Zabaleta Murguionda M, Riesco Miranda JA, Pellicer Ciscar C, Hernandez Hernandez JR, Carrillo Diaz T, Lumbreras Garcia G. [Cost and management of asthma exacerbations in Spanish hospitals (COAX study in hospital services)] Arch Bronconeumol. 2005;41:313–21.
    1. Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, Ernst P. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J. 2002;20:260–7.
    1. Piecoro LT, Potoski M, Talbert JC, Doherty DE. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res. 2001;36:357–71.
    1. Chuesakoolvanich K. Cost of hospitalizing asthma patients in a regional hospital in Thailand. Respirology. 2007;12:433–8.
    1. Laurier C, Kennedy W, Malo JL, Par M, Labb D, Archambault A. Rate and cost of hospitalizations for asthma in Quebec: An analysis of 1988/89, 1989/90 and 1994/95 data. Chronic Dis Can. 1999;20:82–8.
    1. Sailly JC, Lenne X, Bercez C, Lebrun T, Tonnel AB, Tillie-Leblond I. Costs of hospitalization for severe acute asthma of patients not treated according to guidelines and recommendations: French prospective study of 169 cases. Eur J Health Econ. 2005;6:94–101.
    1. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985–1994. J Allergy Clin Immunol. 2000;106:493–9.
    1. Huang ZJ, LaFleur BJ, Chamberlain JM, Guagliardo MF, Joseph JG. Inpatient childhood asthma treatment: relationship of hospital characteristics to length of stay and cost: analyses of New York State discharge data, 1995. Arch Pediatr Adolesc Med. 2002;156:67–72.
    1. Kiivet RA, Kaur I, Lang A, Aaviksoo A, Nirk L. Costs of asthma treatment in Estonia. Eur J Public Health. 2001;11:89–92.
    1. Beyhun NE, Cilingiroglu N, Sekerel BE. The cost of childhood asthma and its determinants in Ankara, Turkey. Turk J Pediatr. 2007;49:179–88.
    1. Neville RG, Hoskins G, Smith B, McCowan C. The economic and human costs of asthma in Scotland. Prim Care Respir J. 2003. pp. 115–8.
    1. Chan PW, Hussain S, Ghani NH, Debruyne JA, Liam CK. The direct cost of treating bronchial asthma in a teaching hospital in Malaysia. Southeast Asian J Trop Med Public Health. 2002;33:600–3.
    1. Szucs TD, Anderhub HP, Rutishauser M. Determinants of health care costs and patterns of care of asthmatic patients in Switzerland. Schweiz Med Wochenschr. 2000;130:305–13.
    1. Korhonen K, Reijonen TM, Remes K, Malmstrom K, Klaukka T, Korppi M. Reasons for and costs of hospitalization for pediatric asthma: a prospective 1-year follow-up in a population-based setting. Pediatr Allergy Immunol. 2001;12:331–8.
    1. Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX) Respir Med. 2006;100:434–50.
    1. Li JT, Xakellis G, Edell ES, Angstman GL. Concentration of healthcare costs in asthma. Am J Manag Care. 1995;1:137–40.
    1. Plaza V, Serra-Batlles J, Ferrer M, Morejon E. Quality of life and economic features in elderly asthmatics. Respiration. 2000;67:65–70.
    1. Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S. Risk factors and costs associated with an asthma attack. Thorax. 2000;55:19–24.
    1. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104:957–63.
    1. Valovirta E, Kocevar VS, Kaila M, Kajosaari M, Koivikko A, Korhonen K, Linna O, Makela M, Remes K, Ben-Joseph RH. Inpatient resource utilisation in younger (2–5 yrs) and older (6–14 yrs) asthmatic children in Finland. Eur Respir J. 2002;20:397–402.
    1. Blainey D, Lomas D, Beale A, Partridge M. The cost of acute asthma–how much is preventable? Health Trends. 1990;22:151–3.
    1. Armstrong EP, Krueger K, Langley PC. Analysis of asthma-related costs and patterns of resource utilization in a managed-care population. Dis Manag Health Outcomes. 2001;9:161–71.
    1. Atherly A, Williams SG, Redd SC. What is the cost of asthma to employers? Drug Benefit Trends. 2003;15:3538–4043.
    1. Rico-Mendez FG, Barquera S, Cabrera DA, Escobedo S, Ochoa LG, Massey-Reynaud LF. Bronchial asthma healthcare costs in Mexico: analysis of trends from 1991–1996 with information from the Mexican Institute of Social Security. J Investig Allergol Clin Immunol. 2000;10:334–41.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa